Eli Lilly and Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2022
Total Assets: $49.49B
Liabilities Breakdown FY2022
Total Liabilities: $38.84B
Asset Breakdown
Total Assets: $49.49B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.07B | 4.2% |
| Accounts Receivable | $6.90B | 13.9% |
| Inventory | $4.31B | 8.7% |
| Property, Plant & Equipment | $10.14B | 20.5% |
| Goodwill | $4.07B | 8.2% |
| Intangible Assets | $7.21B | 14.6% |
| Other Assets | $14.79B | 29.9% |
Liabilities Breakdown
Total Liabilities: $38.84B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.93B | 5.0% |
| Long-Term Debt | $14.74B | 37.9% |
| Other Liabilities | $22.17B | 57.1% |